You are here

  • Home
  • Archive
  • Volume 27, Issue 4
  • Combined Oral Medroxyprogesterone/Levonorgestrel-Intrauterine System Treatment for Women With Grade 2 Stage IA Endometrial Cancer

Article metrics

Article menu
Download PDFPDF
Uterine Cancer
Combined Oral Medroxyprogesterone/Levonorgestrel-Intrauterine System Treatment for Women With Grade 2 Stage IA Endometrial Cancer

 

Online download statistics by month:

Online download statistics by month: February 2019 to October 2024

AbstractFullPdf
Feb 20191200
Mar 20192800
Apr 20194301
May 20195901
Jun 20193400
Jul 20194602
Aug 20194600
Sep 20197602
Oct 20194601
Nov 20194804
Dec 20194401
Jan 20203700
Feb 20204205
Mar 20201702
Apr 20202701
May 20203401
Jun 20209605
Jul 20203400
Aug 20205002
Sep 20204501
Oct 20203600
Nov 20202301
Dec 20202701
Jan 202110000
Feb 20215200
Mar 20214901
Apr 20212303
May 20211803
Jun 2021200
Jul 2021100
Aug 2021402
Sep 2021301
Oct 20214200
Nov 20215303
Dec 20214200
Jan 20223802
Feb 20227400
Mar 20228104
Apr 20228305
May 20225902
Jun 20227200
Jul 20224900
Aug 20227202
Sep 202210102
Oct 20227802
Nov 20224900
Dec 20228802
Jan 20236801
Feb 202311601
Mar 20236900
Apr 20237300
May 20235201
Jun 20232301
Jul 20234602
Aug 20234902
Sep 20234001
Oct 20235202
Nov 20236002
Dec 20238100
Jan 20243400
Feb 20244901
Mar 20247504
Apr 20248900
May 202413702
Jun 20246801
Jul 20245801
Aug 20245100
Sep 202415403
Oct 2024600
Total3633090